We examined the anti-metastatic effect of 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) isolated from wasabi (Wasabia japonica MATSUM). Pulmonary micrometastasis was quantified using a dependable method to detect the human c-Ha-ras gene, which was carried in the tumor cell line. Mice belonging to the S-1 group were administered 6-MITC continuously for 35 days from the time of tumor cell inoculation, and S-2 group mice were administered 6-MITC for 21 days from the day of amputation. Oral administration of 200 M 6-MITC solution was effective in preventing metastasis of the experimental tumor. In the S-1 group, 7 out of ten experimental mice have lungs carrying no detectable human c-Ha-ras gene. Amplified human c-Ha-ras bands were detected in only the lungs of three mice; in these, the metastatic indexes of the lungs were respectively 0.60, 0.70 and 0.90. In the S-2 group, the bands were detected in four lungs of 5 experiments, with the metastatic indexes of the lungs in the range 0.36-0.72. Starting the treatment at the time of tumor cell inoculation was more effective in preventing metastasis than beginning the treatment on the day of amputation.
Many food plant ingredients affect physiological functions such as activation of the immune system, suppression of tumor development, induction of cellular differentiation, and activation of cell proliferation (Osawa, 1995) . Among them, wasabi (Wasabia japonica MATSUM), a typical pungent spice in Japan, not only affects appetite but also inhibits platelet aggregation (Kumagai et al., 1994) and anti-microbial activity (Isshiki & Tokuoka, 1993) . Recently, wasabi has also been reported to inhibit the growth of Helicobacter pylori in the stomach (Kinae et al., 2001) and to suppress 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NKK)-induced lung tumorigenesis in mice (Yano et al., 2000) . We have reported that a specific fraction of wasabi inhibits the growth of human stomach cancer cells in vitro (Fuke et al., 1994) . The active ingredient of this fraction has been identified as 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC), which is not a pungent component of wasabi but an aromatic one (Ono et al., 1996; Etoh et al., 1990a; Etoh et al., 1990b) . Oral administration of 6-MITC also suppressed the development of experimentallyinduced mouse papilloma via a two-stage process in which 9,10dimethyl-1, 2-benzanthracene (DMBA) acts as an initiator and 2o-tetradecanoylphorbol-13-acetate (TPA) as a promoter (Fuke et al., 1997) . Fuke et al. (1997) also found that 6-MITC induces quinone oxidoreductase (QR) in murine Hepa1c1c7 cell, phase II detoxication enzymes in the liver. Furthermore, Hou et al. (2000) reported that 6-MITC significantly induces QR activity, and that this induction is regulated at the transcription level by the QR gene. Meanwhile, we have established a mouse cell line, r/ mHM-SFME-1, which spontaneously metastasized into the lung of a syngeneic Balb/c mouse from a tumor which grew on the back or footpad where the cells were inoculated (Nomura et al., 1993) . Using this cell line, we have reported a dependable method for quantifying the microscopically indistinguishable pulmonary micrometastasis by detecting the human c-Ha-ras gene which is carried in the tumor cell line (Matano et al., 1995) . Also using this cell line, we have previously reported that the oral administration of 400 M 6-MITC effectively suppresses the pulmonary metastasis of the tumor cells . However, in the previous experiments, decreased intake of water containing 6-MITC was observed. In the current work, the reduced water intake recovered to the normal level with half the dosage that was used in previous experiments. Improving the water intake problem, the potential of 6-MITC for the chemo-prevention of tumor progression was studied. Concerning the control of tumor malignancy by a diet component, an altered administration schedule was adopted.
Materials and Methods
Materials The active ingredient from wasabi, 6-MITC, was chemically synthesized by Shiratori Pharmaceutical Co. (Chiba). The 6-MITC was supplied to mice in sterile water, even though it is soluble in organic solvents.
Cell and culture A tumor cell line, r/mHM-SFME-1, was originally derived from mouse embryonic fibroblast SFME (Loo et al., 1987) and established by the introduction of activated hu-E-mail: fuke@tmca.ac.jp man c-Ha-ras and myc genes (Nomura et al., 1993; Shirahata et al., 1990) . Cells were cultured with a mixture of Hames F12 and Dulbecco's modified Eagle medium (F/D, 1 : 1) (Sigma, St. Louis, MO) supplemented with 10% fetal bovine serum (FBS: Cosmo Bio Co., Tokyo) in 5% CO 2 at 37˚C.
Detection of micrometastasis Six-week-old Balb/c female mice were subcutaneously injected with r/mHM-SFME-1 cells (5ϫ10 5 ) into the right hind footpads. The tumor-bearing legs of all control, S-1 and S-2 mice were amputated 14 days after inoculation. The total DNA from the lungs was extracted 35 days after inoculation. Since mouse Ha-ras has a Hind III site in its exon-1 but the human form does not, the total DNA was at first digested completely with Hind III (Takara Co., Tokyo). Undigested human c-Ha-ras exon-1 was amplified by 30 cycles of PCR, and detected by agarose gel electrophoresis. Each band of amplified human Ha-ras exon-1 was quantified by measuring the band area. Based on a standard band with 1ϫ10 4 tumor cells, the metastatic index was calculated by dividing the total area of each sample by that of the standard .
Administration of 6-MITC For the oral administration to mice, 200 M 6-MITC was prepared under sterile conditions and supplied as a beverage. S-1 group mice were continuously supplied with 6-MITC for 35 days from the time of tumor cell inoculation. S-2 group mice were supplied continuously for 21 days from the day of amputation. The control mice and the normal mice (i.e., those without tumors) were supplied with sterile water instead of the 6-MITC solution. The numbers of S-1, S-2, control and normal mice were respectively 10, 6, 6, and 3. However, DNA of one lung of a mouse in the S-2 group was not obtained, with the result that data were only available for 5 of the S-2 mice.
Results and Discussion
Administration of a lower 6-MITC concentration In the previous study, all the lung DNA samples from the tumor-bearing mice which received oral administration of 40 M 6-MITC showed clear bands of human c-Ha-ras exon-1 with metastasized tumor cells. In contrast, only one mouse lung in the five mice supplied with 400 M 6-MITC expressed a human c-Ha-ras band. The water intake of these treated mice, however, was 60% of that of non-treated control mice . For this reason, in the current study, the concentration of 6-MITC orally administered to the mice was 200 M 6-MITC. Although the reduced water intake was observed in the experimental animals, the body weights of these mice were not affected by the administration of 6-MITC at this concentration (Table 1) . A reduced body weight was observed at day 18 in all tumor-bearing mice (controls, S-1 and S-2 mice), and it recovered within two weeks. This body weight alteration was observed independently of 6-MITC administration. Since the tumor-bearing right legs of all these mice were amputated 14 days after inoculation, the observed reduction of body weight is believed to have been caused by surgical stress.
Effect of oral administration of 6-MITC on tumor metastasis In the previous study, effective suppression of tumor metastasis with 400 M 6-MITC was obtained by oral administration for 21 days, starting immediately after the amputation. In order to investigate the preventive effect of 200 M 6-MITC on tumor progression, mice in the S-1 group were treated with 6-MITC continuously for 35 days from the time of tumor cell inoculation. Mice in the S-2 group, however, were given 6-MITC for 21 days, i.e. the same treatment as in previous experiments. The control mice were given only water and not the 6-MITC solution. Mean   Fig. 1 . Pulmonary metastasis detected by tumor-carrying genes. Human c-Ha-ras exon-1 (123 bp, indicated by arrowhead) detected in PCR (30 cycles) amplified by 1 l of Hind III digested mouse lung (tumor cell) DNA as template. Mice were inoculated with 5ϫ10 5 r/mHM-SFME-1 tumor cells on their right hind footpads. M=⌽X174-HaeIII; (ϩ)ϭ1ϫ10 4 r/mHM-SFME-1 DNA; Cntrol Lane 1-6ϭDNA samples from the lungs of control mice; S-1 lanes 1-10ϭDNA samples from the lungs of S-1 group mice; S-2 lanes 1-5ϭDNA samples from the lungs of S-2 group mice.
The amplified human c-Ha-ras band was detectable in every lung sample from each of the control mice 35 days after inoculation with the tumor cells ( Fig. 1, Table 2 ); this represents pulmonary metastasis of tumor cells from the footpad (Matano et al., 1995) . The range of metastatic indexes of these control mouse lungs was 0.64-1.00. In the S-1 group, the bands were detected only in three out of ten mice lungs, with the metastatic indexes of these lungs equal to 0.60, 0.70 and 0.90 respectively. The lungs of the other seven mice showed no evidence of human genes following PCR with 30 cycles of amplification. In the S-2 group, the bands were detected in four mice lungs out of the 5, with the metastatic indexes of these lungs ranging from 0.36 to 0.72, i.e. somewhat lower than for the controls. There were no differences between the samples, including controls, in the results of PCR for the housekeeping GAPDH (glyceraldehyde-3-phosphate dehydrogenase) gene (data not shown). The above results suggest that oral administration of 200 M 6-MITC is effective in preventing metastasis of the experimental tumor.
It is possible that tea polyphenols (including catechins) suppress tumor metastasis (Taniguchi et al., 1992; Menon et al., 1999) . However, little is known about whether food ingredients can inhibit tumor progression. When investigating such effects, one experimental cell line (r/mHM-SFME-1) has marked advantages (Nomura et al., 1993; Matano et al., 1995; Fuke et al., 2000) . First, non-athymic syngeneic Balb/c mice with this cell line are available. Since the immune system of this mouse is entirely intact, this system reflects human tumor progression much more closely than other animal models. Second, metastasized cells are quantitatively detectable in many organs by PCR amplification of the human c-Ha-ras exon-1 oncogene in the tumor cell. This system is thus extremely useful because it is able to detect very small tumors or tumor cells which are undetectable with conventional microscopes. For these reasons, we selected r/ mHM-SFME-1 cells as the means to evaluate the effect of 6-MITC in Balb/c mice. Tumors develop into a metastatic disaster via four stages. This tumor progression includes growth of the tumor at the original site (the inoculated site); detachment of the cells from the original tumor and invasion via the circulatory system; lodgment of the detached cells in neighboring tissues; and outgrowth of the tumor into the invaded organs (completion of metastasis). Amputation of the tumor-bearing leg cuts off the invasive cell supply from the original tumor. Thus, administration of 6-MITC at the time of amputation means that it is only acting against the metastasized cells. However, when 6-MITC is administered at the time of cell inoculation, it is active in all the stages involved in tumor development and not only in the tumor progression that involves the growth of metastasized cells.
In this experiment, metastasis was effectively suppressed by 200 M 6-MITC, although the effect of this dosage was less clear than in the previous study using a concentration of 400 M. However, the reduction of water intake recovered to the control level, with the result that body weight was not affected. With regard to tumor progression, a continuous supply of 200 M 6-MITC for 35 days from the time of tumor cell inoculation was much more effective than administration for 21 days from the time of amputation (14 days after inoculation). It is, however, necessary to determine the optimal timing more precisely. Nevertheless, the previous and present results suggest that the oral administration of 6-MITC is effective in preventing the progression of the experimental tumor.
Using this system for detection, Hatayama et al. (2001) have reported that apple-derived polyphenol suppresses tumor metastasis. After 2 weeks of pre-administration of the apple polyphenol in drinking water (0.05%), mice were inoculated with r/ mHM-SFME-1 cells on their left footpads. The polyphenol was continuously supplied in drinking water for another 4 weeks, and the mice lungs were then examined for signs of metastasis. This treatment was found to be effective in suppressing the metastasis.
Other researchers have also examined the anti-metastatic effects of food ingredients in vivo (Taniguchi et al., 1992; Menon et al., 1999) . One of the ingredients, epigallocatechin gallate, effectively reduced the spontaneous metastasis of B16 melanoma following 21 days of continuous oral administration after the amputation (Taniguchi et al., 1992) . Crucumin combined with catechin also reduced the artificial metastasis of B16 melanoma following by 10 days' continuous oral administration (Menon et al., 1999) . We found that administration from an early stage of tumor development was more effective than administration at a more advanced phase (such as at the time of amputation). The low dosage of 6-MITC was sufficient to suppress tumor progression. Since cancers are not necessarily fatal if tumor progression can be prevented, our results strongly suggest that 6-MITC is a candidate for inclusion in a diet aimed at effectively controlling tumor progression. 
